Prevnar Vaccination After Splenectomy
For post-splenectomy patients who are vaccine-naïve, administer 1 dose of PCV13 (or the newer PCV15/PCV20) followed by PPSV23 at least 8 weeks later, then a second dose of PPSV23 five years after the first dose. 1, 2, 3
Pneumococcal Conjugate Vaccine (Prevnar) Dosing
For Previously Unvaccinated Patients
- Administer a single dose of PCV13 (or preferably PCV20 if available) as the initial pneumococcal vaccine. 4, 2, 3
- If using PCV13 or PCV15, follow with PPSV23 at least 8 weeks after the conjugate vaccine. 1, 2, 3
- If PCV20 is used, no additional PPSV23 is needed, as PCV20 provides complete pneumococcal coverage for all 20 serotypes. 4
For Patients With Prior Vaccination History
- If the patient received 1-3 doses of Prevnar previously: Give 1 additional dose of Prevnar, then PPSV23 6-8 weeks after the last Prevnar dose. 1
- If the patient received 4 doses of Prevnar: Give PPSV23 6-8 weeks after the last Prevnar dose (no additional Prevnar needed). 1
- If the patient received only PPSV23 previously: Give 2 doses of Prevnar 6-8 weeks apart. 1
- For patients previously vaccinated with PCV13 only, give PCV20 at least 1 year later. 2
Booster Dosing
- Administer a second dose of PPSV23 five years after the first PPSV23 dose. 1, 2, 3
- Revaccinate with PPSV23 every 5-10 years for lifelong protection. 2, 3
Optimal Timing Considerations
Elective Splenectomy
- Administer all vaccines at least 2 weeks (ideally 2-6 weeks) before elective surgery to ensure optimal antibody response. 1, 2, 3, 5
- The 2-week pre-surgery timing results in higher antibody concentrations compared to shorter intervals. 2
Emergency/Traumatic Splenectomy
- Wait at least 14 days post-operatively before vaccinating once the patient is clinically stable. 2, 5
- Research demonstrates that immediate post-operative vaccination (within 72 hours) produces similar antibody responses to normal controls, though current guidelines recommend waiting 2 weeks. 6
Critical Additional Vaccines Required
Beyond Prevnar, asplenic patients require comprehensive vaccination:
Meningococcal Vaccines (Urgent Priority)
- Administer both MenACWY and MenB vaccine series. 4, 2, 3
- MenACWY: Give 2 doses separated by 8 weeks. 4, 2
- MenB: Administer as 2-dose or 3-dose series depending on formulation. 4, 2
- Revaccinate with MenACWY every 5 years lifelong. 1, 4, 2, 3
- MenB booster needed at 1 year, then every 2-3 years if risk persists. 4, 2
Haemophilus Influenzae Type B (Hib)
Annual Influenza Vaccine
- Give annual inactivated or recombinant influenza vaccine. 2, 3
- Never use live attenuated influenza vaccine (nasal spray) in asplenic patients. 3
Common Pitfalls to Avoid
Forgetting Lifelong Revaccination
- Protection wanes over time, and infection risk persists for life. 2, 3
- Overwhelming post-splenectomy infection (OPSI) has been reported more than 20 years after splenectomy, with mortality rates of 30-70%. 2, 3
- Streptococcus pneumoniae accounts for approximately 50% of OPSI cases. 2
Inadequate Meningococcal Coverage
- Meningococcal infections in asplenic patients carry 40-70% mortality rates. 3
- Both MenACWY and MenB are required; one alone is insufficient. 4, 3
Suboptimal Timing in Special Populations
- Patients who received rituximab in the previous 6 months may have suboptimal vaccine response. 2
- Vaccination should be reassessed once B-cell recovery has occurred. 2
Additional Protective Measures
Antibiotic Prophylaxis
- Initiate lifelong penicillin prophylaxis immediately post-splenectomy, regardless of vaccination status. 4, 2, 3
- Highest priority in the first 2 years post-splenectomy. 2, 3
Patient Education
- Educate patients about lifelong infection risk and the need to seek immediate medical attention for fevers >101°F (38°C). 2, 3
- Provide emergency standby antibiotics (amoxicillin) for home use at first sign of fever, malaise, or chills. 2, 3
- Issue Medic-Alert identification indicating asplenic status. 2